相关实验视频

Updated: Jun 14, 2026

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

设计小合成抑制剂的计算工具选择性XIAP-BIR3域名的小合成抑制剂

Marc Farag¹, Charline Kieffer¹, Nicolas Guedeney¹

¹Normandie Univ., UNICAEN, CERMN, 14000 Caen, France.

Molecules (Basel, Switzerland)

|July 14, 2023

概括

研究人员开发了一个计算模型来设计选择性XIAP-BIR3抗剂用于癌症治疗. 这种方法通过识别关键残留物来优化药物设计,从而提高选择性和减少副作用.

科学领域:

生物化学生物化学
计算化学计算化学
药理学药理学是指药理学的学科.

背景情况:

过度表达X关联抑制剂的亡蛋白 (XIAP) 通过抑制亡,促进癌细胞的存活.
准XIAP-BIR3域是一个有前途的策略,以恢复癌症治疗中的亡.
目前的XIAP-BIR3抗剂缺乏选择性,抑制cIAP1-2并引起副作用.

研究的目的:

使用理论模型设计和优化选择性合成XIAP-BIR3抗剂.
为了确定选择性XIAP-BIR3抑制的关键分子特征和残留物.
通过最大限度地减少非目标效应,提高XIAP抗体的治疗潜力.

主要方法:

使用MM-PBSA的分子动力学模拟来预测结合亲缘关系.
采用质量分配和相互作用来提高模拟精度.
基于计算预测生成和优化3D药.

主要成果:

一个五个特征的药模型准确地预测了XIAP-BIR3连接体的结合.
确定了九种关键的残留物 (Thr308,Glu314,Trp323,Leu307,Asp309,Trp310,Gly306,Gln319,Lys297) 对于连接物相互作用.
突出了Lys297,Thr308和Asp309作为增强XIAP-BIR3与cIAP-BIR3选择性的关键目标.

结论:

开发的计算模型使选择性XIAP-BIR3对手的设计成为可能.
针对特定的残留物可以提高药物选择性并减少不良影响.
这一战略对开发具有增强安全性概况的新型癌症疗法充满希望.

关键词:

3D药物学家 3D药物学家 MM-PBSA免费能源预测的预测在XIAP-BIR3中使用.分子动力学分子动力学合成抑制剂的合成抑制剂

更多相关视频

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

相关概念视频

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...